JP2023550203A5 - - Google Patents
Info
- Publication number
- JP2023550203A5 JP2023550203A5 JP2023548542A JP2023548542A JP2023550203A5 JP 2023550203 A5 JP2023550203 A5 JP 2023550203A5 JP 2023548542 A JP2023548542 A JP 2023548542A JP 2023548542 A JP2023548542 A JP 2023548542A JP 2023550203 A5 JP2023550203 A5 JP 2023550203A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- approximately
- concentration
- rigf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026024189A JP2026102579A (ja) | 2020-10-19 | 2026-02-18 | 新生児における使用に好適な組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063093696P | 2020-10-19 | 2020-10-19 | |
| US63/093,696 | 2020-10-19 | ||
| PCT/US2021/055598 WO2022086953A1 (en) | 2020-10-19 | 2021-10-19 | Compositions suitable for use in neonates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026024189A Division JP2026102579A (ja) | 2020-10-19 | 2026-02-18 | 新生児における使用に好適な組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023550203A JP2023550203A (ja) | 2023-11-30 |
| JP2023550203A5 true JP2023550203A5 (cg-RX-API-DMAC10.html) | 2024-09-30 |
| JP7827315B2 JP7827315B2 (ja) | 2026-03-10 |
Family
ID=78622033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548542A Active JP7827315B2 (ja) | 2020-10-19 | 2021-10-19 | 新生児における使用に好適な組成物 |
| JP2026024189A Pending JP2026102579A (ja) | 2020-10-19 | 2026-02-18 | 新生児における使用に好適な組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026024189A Pending JP2026102579A (ja) | 2020-10-19 | 2026-02-18 | 新生児における使用に好適な組成物 |
Country Status (24)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250099541A1 (en) | 2022-01-19 | 2025-03-27 | Oak Hill Bio Ltd | Compositions and methods for reducing oxidation of igf-1/igfbp |
| CA3248280A1 (en) | 2022-05-04 | 2023-11-09 | Oak Hill Bio Limited | POLYTHERAPY FOR PREMATURE INFANTS |
| WO2023242439A1 (en) * | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Vascular stabilisation (preterm infants) |
| WO2023242440A1 (en) * | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Treament of lungs in infants |
| EP4598630A1 (en) * | 2022-10-04 | 2025-08-13 | Oak Hill Bio Limited | Method of treating neonates with igf-1 complex |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71991A (en) | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| ATE90690T1 (de) | 1987-04-06 | 1993-07-15 | Celtrix Pharma | Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. |
| DK131988A (da) | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
| US5258287A (en) | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
| ATE132164T1 (de) | 1988-04-12 | 1996-01-15 | Amgen Boulder Inc | Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors |
| GB8826451D0 (en) | 1988-11-11 | 1988-12-14 | Sandoz Ltd | Improvements in/relating to organic compounds |
| IL92816A0 (en) | 1988-12-22 | 1990-09-17 | Biogrowth Inc | Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides |
| EP0639981A4 (en) | 1992-05-08 | 1995-06-28 | Univ Jefferson | ANALOGS OF THE IGF FACTOR (01/18/94). |
| US5563046A (en) | 1993-08-02 | 1996-10-08 | Celtrix Pharmaceuticals, Inc. | Fusion polypeptides and proteins |
| US5789547A (en) | 1995-06-07 | 1998-08-04 | Celtrix Pharmaceuticals, Inc. | Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding |
| US5783556A (en) * | 1996-08-13 | 1998-07-21 | Genentech, Inc. | Formulated insulin-containing composition |
| EP0956041A1 (en) * | 1996-09-16 | 1999-11-17 | Dalhousie University | Use of igf-i for the treatment of polycystic kidney disease and related indications |
| US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| US6436897B2 (en) * | 1998-06-01 | 2002-08-20 | Celtrix Pharmaceuticals, Inc. | Pharmaceutical formulations for IGF/IGFBP |
| US20020028764A1 (en) * | 2000-09-04 | 2002-03-07 | Aarhus Amt. | Treatment of acute and chronic liver disease |
| JP2008543839A (ja) * | 2005-06-14 | 2008-12-04 | アムジェン インコーポレーテッド | 自己緩衝タンパク質製剤 |
| RU2558821C2 (ru) * | 2009-11-17 | 2015-08-10 | Ипсен Фарма С.А.С. | ЛЕКАРСТВЕННАЯ ФОРМА ДЛЯ КОМБИНАЦИИ hGH И rhIGF-1 |
| US20110152188A1 (en) * | 2009-12-23 | 2011-06-23 | Hanns-Christian Mahler | Pharmaceutical compositions of igf/i proteins |
| CA2897062A1 (en) * | 2013-01-15 | 2014-07-24 | Teva Pharmaceutical Industries Ltd. | Lyophilization process |
| KR20140119396A (ko) * | 2013-03-29 | 2014-10-10 | 삼성전자주식회사 | 단백질 약물의 액상 제형 |
| EP3681602B1 (en) * | 2017-09-11 | 2026-04-15 | Oak Hill Bio Limited | Compositions for reducing the incidence of bpd |
| US20250099541A1 (en) * | 2022-01-19 | 2025-03-27 | Oak Hill Bio Ltd | Compositions and methods for reducing oxidation of igf-1/igfbp |
| WO2023139250A1 (en) * | 2022-01-24 | 2023-07-27 | Oak Hill Bio Limited | Lot release assays for igf‐1/igfbp complexes |
-
2021
- 2021-10-19 KR KR1020237016217A patent/KR20230113287A/ko active Pending
- 2021-10-19 JP JP2023548542A patent/JP7827315B2/ja active Active
- 2021-10-19 ES ES21807381T patent/ES3005966T3/es active Active
- 2021-10-19 RS RS20250138A patent/RS66493B1/sr unknown
- 2021-10-19 CN CN202180071124.7A patent/CN117098547A/zh active Pending
- 2021-10-19 FI FIEP21807381.5T patent/FI4228676T3/fi active
- 2021-10-19 US US18/249,414 patent/US20230381285A1/en active Pending
- 2021-10-19 TW TW110138769A patent/TWI912393B/zh active
- 2021-10-19 CA CA3194764A patent/CA3194764A1/en active Pending
- 2021-10-19 PT PT218073815T patent/PT4228676T/pt unknown
- 2021-10-19 HU HUE21807381A patent/HUE070409T2/hu unknown
- 2021-10-19 SM SM20250093T patent/SMT202500093T1/it unknown
- 2021-10-19 WO PCT/US2021/055598 patent/WO2022086953A1/en not_active Ceased
- 2021-10-19 HR HRP20250193TT patent/HRP20250193T1/hr unknown
- 2021-10-19 PL PL21807381.5T patent/PL4228676T3/pl unknown
- 2021-10-19 MX MX2023004426A patent/MX2023004426A/es unknown
- 2021-10-19 LT LTEPPCT/US2021/055598T patent/LT4228676T/lt unknown
- 2021-10-19 AU AU2021364523A patent/AU2021364523A1/en active Pending
- 2021-10-19 SI SI202130265T patent/SI4228676T1/sl unknown
- 2021-10-19 DK DK21807381.5T patent/DK4228676T3/da active
- 2021-10-19 EP EP21807381.5A patent/EP4228676B1/en active Active
- 2021-10-19 IL IL301688A patent/IL301688A/en unknown
- 2021-10-19 EP EP24221637.2A patent/EP4534073A3/en active Pending
-
2023
- 2023-02-28 ZA ZA2023/03162A patent/ZA202303162B/en unknown
- 2023-04-06 SA SA523440271A patent/SA523440271B1/ar unknown
-
2026
- 2026-02-18 JP JP2026024189A patent/JP2026102579A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2393180T3 (es) | Preparados de insulina libre de cinc o con bajo contenido en cinc con estabilidad mejorada | |
| JP7202272B2 (ja) | インスリン分泌性ペプチドの安定な水性非経口医薬組成物 | |
| US6034054A (en) | Stable insulin formulations | |
| JP4589018B2 (ja) | エリスロポエチン溶液製剤 | |
| KR100266502B1 (ko) | 성장호르몬과히스티딘으로이루어지는안정화된약학제제 | |
| US5849700A (en) | Pharmaceutical formulation | |
| FI4228676T3 (fi) | Koostumuksia, jotka sopivat vastasyntyneillä käytettäviksi | |
| EP0921812B1 (en) | Insulin preparations containing a halogenide | |
| US20080248999A1 (en) | Amylin formulations | |
| WO2012130136A1 (zh) | 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用 | |
| ES2391776T3 (es) | Formulaciones solubles, estables conteniendo insulina con una sal de protamina | |
| JP2001199899A (ja) | インスリン類似化合物複合体 | |
| JP2024156754A5 (cg-RX-API-DMAC10.html) | ||
| KR20000076419A (ko) | 폐 투여용 무아연 인슐린 결정 조성물 | |
| JP2002500196A (ja) | 安定化させたインスリン組成物 | |
| JPWO2001064241A1 (ja) | 長期安定化製剤 | |
| KR20150021011A (ko) | 초고도 농축된, 속효성 인슐린 유사체 제형 | |
| JP2002512973A (ja) | タンパク質製剤 | |
| JP2022549328A5 (cg-RX-API-DMAC10.html) | ||
| JP2021511362A5 (cg-RX-API-DMAC10.html) | ||
| CA1335924C (en) | Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus | |
| JP2025114869A5 (cg-RX-API-DMAC10.html) | ||
| JP2010523501A (ja) | Ｇｈｒｈ分子の医薬製剤 | |
| EP1283051B1 (en) | Stable insulin formulations | |
| CA2589889A1 (en) | Therapeutic formulations of keratinocyte growth factor |